C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter C—Drugs: GeneralPart 211—Current Good Manufacturing Practice for Finished PharmaceuticalsSubpart D—Equipment

21 C.F.R. § 211.67 (2026)

Equipment cleaning and maintenance

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1988–2010 5citing cases
At a glance

Courts have cited this section in 5 opinions since 1988.

(a) Equipment and utensils shall be cleaned, maintained, and, as appropriate for the nature of the drug, sanitized and/or sterilized at appropriate intervals to prevent malfunctions or contamination that would alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements.

(b) Written procedures shall be established and followed for cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing, or holding of a drug product. These procedures shall include, but are not necessarily limited to, the following:

(1) Assignment of responsibility for cleaning and maintaining equipment;

(2) Maintenance and cleaning schedules, including, where appropriate, sanitizing schedules;

(3) A description in sufficient detail of the methods, equipment, and materials used in cleaning and maintenance operations, and the methods of disassembling and reassembling equipment as necessary to assure proper cleaning and maintenance;

(4) Removal or obliteration of previous batch identification;

(5) Protection of clean equipment from contamination prior to use;

(6) Inspection of equipment for cleanliness immediately before use.

(c) Records shall be kept of maintenance, cleaning, sanitizing, and inspection as specified in §§ 211.180 and 211.182.

[43 FR 45077, Sept. 29, 1978, as amended at 73 FR 51931, Sept. 8, 2008]
The 5 cases that cite 21 C.F.R. § 211.67 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENIn re Digitek® Prod. Liab. Litig., 264 F.R.D. 249 (S.D. W. Va. 2010).
cites § 211.67 1×cited by 14 cases
Where it cites § 211.67
“[ 21 CFR § 211.67 (b)] For example: a) Cleaning validation was performed for the process trains without evaluating for sample recovery for numerous products, including: .”
The case’s holding
A court considers case complexity and pleading defects as factors when determining whether to enter a Lone Pine order requiring plaintiffs to provide case-specific evidence of toxicity.
Later courts cite it for
“case complexity and pleading defects are additional factors worth considering in advance of entering a lone pine order.” · 8 citing courts
cites § 211.67 1×cited by 28 cases
Where it cites § 211.67
“, 21 C.F.R. § 211.67 (equipment and utensils to be cleaned, maintained, and sanitized at “appropriate intervals”); id.”
Later courts cite it for
“apply with equal force in the context of administrative judgment.” · 3 citing courts
3
GREENCrocker v. Kv Pharm. Co., 782 F. Supp. 2d 760 (E.D. Mo. 2010).
cites § 211.67 1×cited by 12 cases
Where it cites § 211.67
“Failure to clean, maintain, and sanitize equipment and utensils at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product, as required by 21 C.F.R. § 211.67 (a); and g. Failure to follow written…”
Later courts cite it for
“had knowledge of or participated in underlying fiduciary breaches.” · 2 citing courts
4
GREENUnited States v. Barr Labs., Inc., 812 F. Supp. 458 (D.N.J. 1993).
cites § 211.67 1×cited by 13 cases
Where it cites § 211.67
“21 C.F.R. § 211.67 . 140. Repeated FDA criticism of Barr’s failure to validate its cleaning procedures leads the Government to challenge Barr’s compliance with this section of the regulations.”
5
REDPub. Pension Fund Grp. v. Kv Pharm. Co., 705 F. Supp. 2d 1088 (E.D. Mo. 2010).
cites § 211.67 1×cited by 4 cases
Reversed in part by Public Pension Fund Group v. KV PHARMACEUTICAL CO. (2012): the Court of Appeals for the Eighth Circuit's own opinion in this case ("Ill For the reasons stated, we affirm in part, reverse in part, and remand to…
Where it cites § 211.67
“Failure to clean, maintain, and sanitize equipment and utensils at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product, as required by 21 C.F.R. § 211.67 (a); and G. Failure to follow written…”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
198819992010

One bar per year. Tallest: 3 cases in 2010. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
E.D. Mo.2D.C. Cir.1D.N.J.1S.D.W. Va1
By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com